Probiotics; past, present, and future perspectives

Current Pediatric Reviews

Volumn 4, Issue 2, 2008, Pages 96-102

  Michail, Sonia ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Allergy; Gastrointestinal disorders; History; Probiotics

Indexed keywords

AMINOSALICYLIC ACID DERIVATIVE; ANTIBIOTIC AGENT; AZATHIOPRINE; BACILLUS SUBTILIS EXTRACT; BIFIDOBACTERIUM BIFIDUM EXTRACT; BIFIDOBACTERIUM BREVE EXTRACT; BIFIDOBACTERIUM EXTRACT; BIFIDOBACTERIUM INFANTIS EXTRACT; BIFIDOBACTERIUM LACTIS EXTRACT; CORTICOSTEROID; ENTEROCOCCUS EXTRACT; ESCHERICHIA COLI EXTRACT; LACTEOL FORT; LACTOBACILLUS ACIDOPHILUS EXTRACT; LACTOBACILLUS BULGARICUS EXTRACT; LACTOBACILLUS CASEI EXTRACT; LACTOBACILLUS EXTRACT; LACTOBACILLUS LACTIS EXTRACT; LACTOBACILLUS PLANTARUM EXTRACT; LACTOBACILLUS REUTERI EXTRACT; LACTOBACILLUS RHAMNOSUS EXTRACT; LACTOBACILLUS SALIVARIS EXTRACT; MERCAPTOPURINE; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; MUTAFLOR; PLACEBO; PROBIOTIC AGENT; SACCHAROMYCES BOULARDII EXTACT; STOMACH SECRETION INHIBITOR; STREPTOCOCCUS THERMOPHILUS EXTRACT; UNINDEXED DRUG;

ABDOMINAL PAIN; ADJUVANT THERAPY; ALLERGIC DISEASE; ASTHMA; ATOPIC DERMATITIS; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CROHN DISEASE; DIARRHEA; DIET SUPPLEMENTATION; DRUG EFFICACY; ERADICATION THERAPY; GASTROENTERITIS; GASTROINTESTINAL DISEASE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; ILEITIS; INFECTIOUS DIARRHEA; INTESTINE FLORA; IRRITABLE COLON; LACTOBACILLUS ACIDOPHILUS; LOW DRUG DOSE; NECROTIZING ENTEROCOLITIS; NONHUMAN; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; TRAVELLER DIARRHEA; ULCERATIVE COLITIS;

EID: 47749105013     PISSN: 15733963     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339608784462034     Document Type: Review

References (46)

1. Lilly D, Stillwell R. Probiotics. Growth promoting factors produced by micro-organisms. Science 1965; 147: 747-8.
2. Bottazzi V. Food and feed production with microorganisms. Biotechnology (N Y) 1983; 5: 315-63.
3. Metchnikoff E. Études sur la flore intestinale. Ann Inst Pasteur Paris 1908; 22: 929-55.
4. Kaplan R. Doctor to the Dictator: the career of Theodor Morell, personal physician to Adolf Hitler. Australas Psychiatry 2002; 10(4): 389-92.
5. Kopeloff N. "Lactobacillus Acidophilus" Williams and Wilkins Co., 1926.
6. Oderda G, Shcherbakov P, Bontems P, et al. Results from the pediatric European register for treatment of Helicobacter pylori (PERTH). Helicobacter 2007; 12(2): 150-6.
7. Grave GD, Nelson SA, Walker WA, et al. New therapies and preventive approaches for necrotizing enterocolitis: report of a research planning worksliop. Pediatr Res 2007; 62(4): 510-4.
8. Barclay AR, Stenson B, Simpson JH, Weaver LT, Wilson DC. Probiotics for Necrotizing Enterocolitis: A Systematic Review. J Pediatr Gastroenterol Nutr 2007; 45(5): 569-76.
9. Deshpande G, Rao S, Patole S. Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials. Lancet 2007; 369(9573): 1614-20.
10. Kosek M, Bern C, Guerrant RL. The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bull World Health Organ 2003; 81(3): 197-204.
11. Saavedra JM, Abi-Harma A, Moore N, Yolken RH. Long-term consumption of infant formulas containing live probiotic bacteria: tolerance and safety. Am J Clin Nutr 2004; 79(2): 261-7.
12. Szajewska H, Kotowska M, Mrakowicz JZ, Armanska M, Mikolajczyk W. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr 2001; 138(3): 361-5.
13. Mastretta E, Longo P, Laccisaglia A, et al. Effect of Lactobacillus GG and breast-feeding in the prevention of rotavirus nosocomial infection. J Pediatr Gastroenterol Nutr 2002; 35(4): 527-31.
14. Weizman Z, Asli G, Alsheikh A. Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 2005; 115(1): 5-9.
15. Szajewska H, Skorka A, Ruszczynski M, Gieruszczak-Bialek D. Meta-analysis: Lactobacillus GG for treating acute diarrhoea in children. Aliment Pharmacol Ther 2007; 25(8): 871-81.
16. Van Niel CW, Feudmer C, Garrison MM, Christakis DA. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 2002; 109(4): 678-84.
17. Huang JS, Bousvaros A, Lee YW, Diaz A, Davidson EJ. Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig Dis Sci 2002; 47(11): 2625-34.
18. Allen SJ, Okoko B, Martinez E, Gregorio G, Dans LF. Probiotics for treating infectious diarrhoea. Cochrane Database Syst Rev 2004(2): CD003048.
19. McFarland LV. Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Med Infect Dis 2007; 5(2): 97-105.
20. Rolfe VE, Fortun PJ, Hawkey CJ, Bath-Hextall F. Probiotics for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2006(4): CD004826.
21. Gupta P, Andrew H, Kirschner BS, Guandalini S. Is lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study. J Pediatr Gastroenterol Nutr 2000; 31(4): 453-7.
22. Bousvaros A, Guandalini S, Baldassano RN, et al. A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease. Inflamm Bowel Dis 2005; 11(9): 833-9.
23. Elahi B, Nikfar S, Derakhshani S, Vafaie M, Abdollahi M. On the Benefit of Probiotics in the Management of Pouchitis in Patients Underwent Ileal Pouch Anal Anastomosis. A Meta-analysis of Controlled Clinical Trials. Dig Dis Sci 2007.
24. Bengmark S. Ecological control of the gastrointestinal tract. The role of probiotic flora. Gut 1998; 42(1): 2-7.
25. Bausserman M, Michail S. The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial. J Pediatr 2005; 147(2): 197-201.
26. Gawronska A, Dziechciarz P, Horvath A, Szajewska H. A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children. Aliment Pharmacol Ther 2007; 25(2): 177-84.
27. Bittner AC, Croffut RM, Stranahan MC, Yokelson TN. Prescript-assist probiotic-prebiotic treatment for irritable bowel syndrome: an open-label, partially controlled, 1-year extension of a previously published controlled clinical trial. Clin Ther 2007; 29(6): 1153-60.
28. Fan YJ, Chen SJ, Yu YC, Si JM, Liu B. A probiotic treatment containing Lactobacillus, Bifidobacterium and Enterococcus improves IBS symptoms in an open label trial. J Zhejiang Univ Sci B 2006; 7(12): 987-91.
29. Whorwell PJ, Altringer L, Morel J, et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 2006; 101(7): 1581-90.
30. Kim HJ, Vazquez Roque MI, Camilleri M, et al. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil 2005; 17(5): 687-96.
31. O'Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005; 128(3): 541-51.
32. Kim HJ, Camilleri M, McKinzie S, et al. A randomized controlled trial of a probictic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2003; 17(7): 895-904.
33. Niedzielin K, Kordecki H, Birkenfeld B. A controlled, doubleblind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 2001; 13(10): 1143-7.
34. O'Sullivan MA, O'Morain CA. Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study. Dig Liver Dis 2000; 32(4): 294-301.
35. Sen S, Mullan MM, Parker TJ, Woolner JT, Tarry SA, Hunter JO. Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome. Dig Dis Sci 2002; 47(11): 2615-20.
36. Brigidi P, Vitali B, Swennen E, Bazzocchi G, Matteuzzi D. Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea. Res Microbiol 2001; 152(8): 735-41.
37. Saggioro A. Probiotics in the treatment of irritable bowel syndrome. J Clin Gastroenterol 2004; 38(6 Suppl): S104-6.
38. Nobaek S, Johansson ML, Molin G, Ahrne S, Jeppsson B. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 2000; 95(5): 1231-8.
39. Tsuchiya J, Barreto I, Okura R, Kawakita S, Fesce E, Marotta F. Single-blind follow-up study on the effectiveness of a symbiotic preparation in irritable bowel syndrome. Chin J Dig Dis 2004; 5(4): 169-74.
40. Halpern GM, Prindiville T, Blankenburg M, Hsia T, Gershwin ME. Treatment of irritable bowel syndrome with Lacteol Fort: a randomized, double-blind, cross-over trial. Am J Gastroenterol 1996; 91(8): 1579-85.
41. Michail S, Onady G, Stolfi A, Johnson T. Efficacy of probiotics in treatment of pediatric atopic dermatitis: a meta-analysis of randomized, controlled trials. Allergy, in review 2008.
42. Osborn DA, Sinn JK. Probiotics in infants for prevention of allergic disease and food hypersensitivity. Cochrane Database Syst Rev 2007(4): CD006475.
43. Giovannini M, Agostoni C, Riva E, et al. A randomized prospective double blind controlled trial on effects of long-term consumption of fermented milk containing Lactobacillus casei in pre-school children with allergic asthma and/or rhinitis. Pediatr Res 2007; 62(2): 215-20.
44. Westendorf AM, Gunzer F, Deppenmeier S, et al. Intestinal immunity of Escherichia coli NISSLE 1917: a safe carrier for therapeutic molecules. FEMS Immunol Med Microbiol 2005; 43(3):373-84.
45. Jijon H, Backer J, Diaz H, et al. DNA from probiotic bacteria modulates munne and human epithelial and immune function. Gastroenterology 2004; 126(5): 1358-73.
46. Rachmilewitz D, Karmeli F, Takabayashi K, et al. Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology 2002; 122(5): 1428-41.